CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![IT Programmer working at desk-GettyImages-1354205042]( "Beyond Traditional CTMS And eTMF")
Beyond Traditional CTMS And eTMFTrial data scattered across spreadsheets, emails, and siloed systems slows teams down. Learn how connecting it gives one clear view that catches risks early and keeps studies inspection-ready.
-
![online document verification, file management, data storage-GettyImages-2265259381]( "The PMCF Decision Guide")
The PMCF Decision GuideProposed EU reforms may remove standalone PMCF reporting, yet the duty to proactively collect clinical data remains. Method selection, notified body defense, and data-capture cost determine what comes next.
-
![GettyImages-1130406792-compliance-regulatory-regulation-meeting]( "Reimagine Quality: Responding To EOL Deadlines")
Reimagine Quality: Responding To EOL DeadlinesDelay, migrate, or reimagine? Learn how rethinking quality operations around AI can triple team productivity and keep you inspection-ready for the next decade.
-
![AI medical interface, DNA, health data-GettyImages-2240353426]( "Everything Clinical Trial Leaders Need To Know About AI Agents")
Everything Clinical Trial Leaders Need To Know About AI AgentsA practical guide to what agentic AI actually means for clinical trials, from ontologies and human-in-the-loop governance to continuous validation and the build-versus-buy decision.
-
![GettyImages-2169874381-digital-ai-development-technology]( "How Clinical Trials Are Moving From Digitized To Agentified")
How Clinical Trials Are Moving From Digitized To AgentifiedSee how generative and agentic AI can streamline clinical trials, with independent analysis modeling up to $21M in value and 82x ROI for agent-enabled monitoring.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.
Signals Clinical streamlines clinical data workflows, reducing the time spent preparing data for analytics. Its comprehensive platform enables the rapid delivery of clinical insights that inform both clinical and operational study decisions.
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.
CENTRAL LABORATORIES SOLUTIONS
- Customer-Centric, Cost-Effective, Quality-Focused Solutions
- Simplify The Complexities Of RWE Generation
- Real World Data Solutions
- The Big Impact Of Medable AI
- Simplify, Centralize, And Control Clinical Trial Disclosure With Ease, Flexibility, And Speed
- pci | bridge: Real-Time Supply Chain Information
- Generate Regulatory-Grade, RWE With Speed And Efficiency
- A Simplified, Accessible Solution For Phase I And Phase IV Trials
- Meet elo - Your Intelligent Data Companion Inside Elosity®
- ICH E6(R3) Is Here: How Should You Handle It?
VIDEOS
NEWS
- Suvoda Makes Sofia AI Assistant Available For Clinical Trials To Drive Faster Answers And Action
- Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation In Clinical Study
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials